Slow Capital’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.62M Buy
49,696
+1,990
+4% +$187K 0.54% 68
2026
Q1
$4.24M Buy
47,706
+10,883
+30% +$1.12M 0.55% 60
2025
Q4
$3.51M Sell
36,823
-5,199
-12% -$524K 0.42% 66
2025
Q3
$4.14M Sell
42,022
-3,324
-7% -$355K 0.49% 62
2025
Q2
$4.83M Sell
45,346
-3,415
-7% -$345K 0.59% 48
2025
Q1
$4.44M Buy
48,761
+34
+0.1% +$3.81K 0.59% 52
2024
Q4
$5.55M Sell
48,727
-2,953
-6% -$337K 0.79% 28
2024
Q3
$6.14M Buy
51,680
+600
+1% +$55.2K 0.94% 22
2024
Q2
$4.1M Buy
51,080
+5,467
+12% +$500K 0.66% 42
2024
Q1
$4.21M Buy
45,613
+16,087
+54% +$1.54M 0.67% 45
2023
Q4
$3.12M Buy
29,526
+4,012
+16% +$404K 0.54% 61
2023
Q3
$2.77M Sell
25,514
-914
-3% -$101K 0.51% 60
2023
Q2
$2.85M Sell
26,428
-1,075
-4% -$121K 0.5% 63
2023
Q1
$3.43M Buy
27,503
+736
+3% +$101K 0.64% 44
2022
Q4
$4.02M Buy
26,767
+5,575
+26% +$858K 0.89% 28
2022
Q3
$2.86M Sell
21,192
-258
-1% -$39.4K 0.62% 38
2022
Q2
$3.2M Buy
21,450
+926
+5% +$141K 0.78% 31
2022
Q1
$3.5M Buy
+20,524
New +$3.45M 0.65% 36

Other funds holding BNTX

Slow Capital's BNTX Position: Q2 2026 in Review

Slow Capital increased its BioNTech (BNTX) stake by 4.2% in Q2 2026, buying an estimated $187K and bringing the position to 49,696 shares worth $4.62M. The position accounts for 0.54% of the portfolio, ranked #68.

Slow Capital first reported a position in BNTX in Q1 2022 and has held it in 18 quarters since. The position peaked at $6.14M in Q3 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Slow Capital held 49,696 shares of BioNTech worth $4.62M as of Q2 2026.
  • Slow Capital bought 1,990 BioNTech shares in Q2 2026, an estimated $187K.
  • BioNTech made up 0.54% of Slow Capital's portfolio in Q2 2026, its #68 holding.
  • Slow Capital first reported a position in BioNTech in Q1 2022 and has held it in 18 quarters since.
  • Slow Capital's BioNTech position peaked at $6.14M in Q3 2024.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Slow Capital's 13F filing for Q2 2026, filed 22 Jul 2026.